GTS Securities’s Langar Global HealthTech ETF LGHT Stock Holding History

GTS Securities’s Portfolio LGHT Stock Details LGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13,759	Closed	-$120K	–	1666
2026 Q1	$120K	Buy	13,759 +1,473	+12%	+$14.2K	﹤0.01%	1415
2025 Q4	$123K	Sell	12,286 -7,516	-38%	-$76.3K	﹤0.01%	1306
2025 Q3	$199K	Sell	19,802 -64,071	-76%	-$659K	0.01%	1302
2025 Q2	$874K	Buy	+83,873	New	+$832K	0.04%	417
2024 Q4	–	Sell	-16,462	Closed	-$177K	–	2814
2024 Q3	$177K	Buy	+16,462	New	+$171K	﹤0.01%	3689
2024 Q2	–	Sell	-15,546	Closed	-$167K	–	4145
2024 Q1	$167K	Buy	+15,546	New	+$160K	﹤0.01%	3402

Other funds holding LGHT

INVST Indianapolis, Indiana $1.03B AUM 29.49% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

GTS Securities's LGHT Position: Q2 2026 in Review

GTS Securities sold out of Langar Global HealthTech ETF (LGHT) in Q2 2026, closing a stake of 13,759 shares — an estimated $120K sold.

GTS Securities first reported a position in LGHT in Q1 2024 and held it in 6 quarters. The position peaked at $874K in Q2 2025. 3 funds tracked by Wall St. Rank hold LGHT as of Q2 2026.

GTS Securities reported no remaining Langar Global HealthTech ETF position as of Q2 2026 after selling out during the quarter.
GTS Securities sold 13,759 Langar Global HealthTech ETF shares in Q2 2026, an estimated $120K.
GTS Securities first reported a position in Langar Global HealthTech ETF in Q1 2024 and held it in 6 quarters.
GTS Securities's Langar Global HealthTech ETF position peaked at $874K in Q2 2025.
3 funds tracked by Wall St. Rank held Langar Global HealthTech ETF as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.